Back to today’s briefing

Story perspectives

Low Hormone Therapy Use Sparks Call for Education Reform

11/6/2025

41 8

Summary

Story summary

In the U.S., hormone therapy prescribing has remained low since the 2002 Women's Health Initiative, with 3.8% of visits involving prescriptions in 2018–2019.
Dr. Anna Caroline Cochrane noted inadequate training to address menopause symptoms and urged physicians to understand the hormone therapy evidence.
Cochrane plans to analyze current prescribing patterns to identify areas for improvement in future research.

1 of 1

Story summary

In the U.S., hormone therapy prescribing has remained low since the 2002 Women's Health Initiative, with 3.8% of visits involving prescriptions in 2018–2019.
Dr. Anna Caroline Cochrane noted inadequate training to address menopause symptoms and urged physicians to understand the hormone therapy evidence.
Cochrane plans to analyze current prescribing patterns to identify areas for improvement in future research.